Recent advances in structure-based rational drug design
- PMID: 10981625
- DOI: 10.1016/s0959-440x(00)00105-6
Recent advances in structure-based rational drug design
Abstract
Two approaches to structure-based drug design, that is, the docking of known compounds into a target protein and molecular assembly in situ, are seen to be merging technologies. The need for structural information about drug-protein complexes is now fundamental for drug discovery.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
